2018 Research Investments After investing in genetic sequencing in 2017, we realized we were just scratching the surface: both in terms of our understanding of pancreatic cancer subtypes, but also in the ways that personalized medicine – which involves treatment...
2017 Research Investments 2017 marked our first year investing in the most cutting-edge research from coast to coast under our PancOne™ research network. We focused our research investments to what was going to make the biggest impact on the research landscape...
2016 Research Investments 2016 was an important year for Pancreatic Cancer Canada and the direction of our research investments. We fulfilled research commitments as part of our Pancreatic Cancer Canada Innovation Grants program, invested in new equipment that aids in...
Our Impact: 2018 2018 was a critical year for Pancreatic Cancer Canada filled with groundbreaking research and new ways to support Canadians affected by this disease. Everything we accomplished, everything we learned, every Canadian we reached, we couldn’t have...
Recent Comments